ErmC' is a methyltransferase that confers resistance to the macrolide-
lincosamide-streptogramin B group of antibiotics by catalyzing the met
hylation of 235 rRNA at a specific adenine residue (A-2085 in Bacillus
subtilis; A-2058 in Escherichia coli). The gene for ErmC' was cloned
and expressed to a high level in E. coli, and the protein was purified
to virtual homogeneity. Studies of substrate requirements of ErmC' ha
ve shown that a 262-nucleotide RNA fragment within domain V of B. subt
ilis 235 rRNA can be utilized efficiently as a substrate for methylati
on at A-2085. Kinetic studies of the monomethylation reaction showed t
hat the apparent K-m of this 262-nucleotide RNA oligonucleotide was 26
-fold greater than the value determined for full-size and domain V 235
rRNA. In addition, the V-max for this fragment also rose sevenfold. A
model of RNA-ErmC' interaction involving multiple binding sites is pr
oposed from the kinetic data presented.